Skip to main content

Octreotide Acetate

NDC 68083-515 · Gland Pharma Limited

Generic nameOctreotide Acetate
Dosage formINJECTION, SOLUTION
RouteINTRAVENOUS, SUBCUTANEOUS
Active ingredient(s)OCTREOTIDE ACETATE
Strength200 ug/mL
Pharmacologic classSomatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]
Marketing categoryANDA

Packages

68083-515-01 — 1 VIAL in 1 CARTON (68083-515-01) / 5 mL in 1 VIAL

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

23155-687 — octreotide acetate, 23155-688 — octreotide acetate, 23155-689 — octreotide acetate, 52958-046 — octreotide acetate, 62756-452 — octreotide acetate, 63323-376 — OCTREOTIDE ACETATE, 63323-377 — OCTREOTIDE ACETATE, 63323-378 — OCTREOTIDE ACETATE, 63323-379 — OCTREOTIDE ACETATE, 67457-239 — octreotide acetate, 67457-245 — octreotide acetate, 67457-246 — octreotide acetate, 68083-516 — Octreotide Acetate, 68083-517 — Octreotide Acetate, 68083-560 — Octreotide Acetate, 68462-896 — Octreotide Acetate, 68462-897 — Octreotide Acetate, 71288-566 — Octreotide Acetate, 71288-567 — Octreotide Acetate, 71288-568 — Octreotide Acetate, +10 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T38.991 — Poisoning by other hormone antagonists, accidental (unintentional), T38.992 — Poisoning by other hormone antagonists, intentional self-harm, T38.993 — Poisoning by other hormone antagonists, assault, T38.994 — Poisoning by other hormone antagonists, undetermined, T38.995 — Adverse effect of other hormone antagonists, T38.996 — Underdosing of other hormone antagonists